Product Information
AZITHROMYCIN 100 MG/5 ML SUSP is a generic product labeled by Epic Pharma LLC, priced at $0.3702 per ML under NDC 42806014731. Its NADAC has been published 428 times since Jul 25, 2018.
FDA first approved this application on Apr 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Epic Pharma LLCNDC
42806014731
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207531FDA Approved
4/9/2018
TE Code
AB
On Market Since
4/10/2018
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 100 MG/5 ML SUSP has been published 428 times since Jul 25, 2018, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3702 per ML |
|---|---|
| All-time high | $0.8375 (Aug 15, 2018) |
| All-time low | $0.3048 (Jul 17, 2024) |
| 52-week high | $0.4004 |
| 52-week low | $0.3529 |
| Median price | $0.5273 |
| Average price | $0.5447 |
| Largest weekly change | +38.7% (Aug 21, 2024) |
| Weeks tracked | 428 |
| Tracking since | Jul 25, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azithromycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 100 MG/5 ML SUSP, manufactured by Epic Pharma LLC, is $0.3702 per ML (NDC 42806014731), effective Sep 30, 2026.
How has the price of AZITHROMYCIN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 100 MG/5 ML SUSP has declined 55.8%. It has been tracked across 428 weekly CMS publications since Jul 25, 2018.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 100 MG/5 ML SUSP?
Since Jul 25, 2018, the NADAC for AZITHROMYCIN 100 MG/5 ML SUSP has ranged from a low of $0.3048 (Jul 17, 2024) to a high of $0.8375 (Aug 15, 2018), with a median of $0.5273 per ML.
Are there cheaper alternatives to AZITHROMYCIN 100 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of AZITHROMYCIN 100 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZITHROMYCIN 100 MG/5 ML SUSP?
AZITHROMYCIN 100 MG/5 ML SUSP (NDC 42806014731) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.